Previous
Next
Welcome to collaborative research.
Where science, technology
and translation converge
Our formula to develop trailblazing drugs and advance health sciences is based on extreme collaboration between three hubs: ambitious scientific research, ever-evolving technological innovation and a constant translational effort of carrying our breakthroughs from bench to bedside.
Latest breakthroughs
Innovation in medicine is happening right now. Keep up with us.
Vale FF, Vítor J, Marques AT, Azevedo-Pereira JM, Anes E, Goncalves J. Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide. Virus Res. 2021; 304, 198526. DOI: 10.1016/j.virusres.2021.198526.
- October 15, 2021
- João Gonçalves
Lee K, Yang A, Lin Y-C, Reker D, Bernardes G.J.L., Rodrigues T. Combating small molecule aggragation with machine learning. Cell Reports Physical Science 2021; 2 (9): 100573. DOI: 10.1016/j.xcrp.2021.100573
- September 22, 2021
- Rui Moreira
Valente E, Testa B, Constantino L. Activation of benzoate model prodrugs by mycobacteria. Comparison with mammalian plasma and liver hydrolysis. Eur J Pharm Sci. 2021, 162:105831. DOI: 10.1016/j.ejps.2021.105831.
- July 1, 2021
- Maria M. M. Santos
imed
December 15, 2021
Partners
We don't act alone. Every in-house member at imed advances our purpose but we also collaborate with some distinguished external partners.
ULisboa
Faculdade de Farmácia
FCT
República Portuguesa
Example Title
